Clinical Trial Update: Ph1 Study of Valortim and Doxycycline in Humans [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating Valortim in combination with doxycycline for anthrax was terminated. The trial status was TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• Doxycycline (Doxycycline)
• Valortim (MDX-1303)

Snippet

Sponsor: PharmAthene, Inc. | Conditions: Anthrax | Phase 1 | Status: TERMINATED